AMED - Amedisys Inc. (AMED) CEO Christopher Gerard on Q1 2022 Results - Earnings Call Transcript
Amedisys, Inc. (AMED) Q1 2022 Earnings Conference Call April 28, 2022, 11:00 ET Company Participants Nick Muscato - Chief Strategy Officer Christopher Gerard - CEO, President & Director Scott Ginn - EVP & CFO David Kemmerly - Chief Legal & Government Affairs Officer Conference Call Participants Brian Tanquilut - Jefferies Matthew Larew - William Blair & Company Justin Bowers - Deutsche Bank John Ransom - Raymond James & Associates Matthew Borsch - BMO Capital Markets Andrew Mok - UBS Benjamin Mayo - SVB Leerink Sarah James - Barclays Bank Joanna Gajuk - Bank of America Merrill Lynch Albert Rice - Crédit Suisse Presentation Operator Greetings, and welcome to Amedisys' Q1 '22 Earnings Conference Call. [Operator Instructions]. I would now like to turn the conference over to your host, Nick Muscato, Chief Strategy Officer. Please go ahead, sir. Nick Muscato Thank you, operator, and welcome to the Amedisys investor conference call
For further details see:
Amedisys, Inc. (AMED) CEO Christopher Gerard on Q1 2022 Results - Earnings Call Transcript